Singapore markets close in 4 hours 14 minutes

CStone Pharmaceuticals (2616.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.170-0.040 (-3.31%)
As of 11:56AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.54B
Enterprise value 828.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.06
Price/book (mrq)3.13
Enterprise value/revenue 1.66
Enterprise value/EBITDA -1.74

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-56.79%
S&P500 52-week change 324.78%
52-week high 33.270
52-week low 30.800
50-day moving average 31.020
200-day moving average 31.743

Share statistics

Avg vol (3-month) 32.63M
Avg vol (10-day) 32.74M
Shares outstanding 51.28B
Implied shares outstanding 61.28B
Float 8629.24M
% held by insiders 147.70%
% held by institutions 114.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -79.17%
Operating margin (ttm)-173.74%

Management effectiveness

Return on assets (ttm)-22.94%
Return on equity (ttm)-81.05%

Income statement

Revenue (ttm)463.84M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)-7.80%
Gross profit (ttm)N/A
EBITDA -586.64M
Net income avi to common (ttm)-367.23M
Diluted EPS (ttm)-0.310
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)0.82
Total debt (mrq)363.45M
Total debt/equity (mrq)79.56%
Current ratio (mrq)1.56
Book value per share (mrq)0.36

Cash flow statement

Operating cash flow (ttm)-588.84M
Levered free cash flow (ttm)-511.62M